{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T02:31:06Z","timestamp":1793327466139,"version":"4.5.0"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:00:00Z","timestamp":1789603200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012544","name":"China Medical University, Taiwan","doi-asserted-by":"publisher","award":["CMU114-MF-18"],"award-info":[{"award-number":["CMU114-MF-18"]}],"id":[{"id":"10.13039\/501100012544","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012544","name":"China Medical University, Taiwan","doi-asserted-by":"publisher","award":["CMU114-MF-32"],"award-info":[{"award-number":["CMU114-MF-32"]}],"id":[{"id":"10.13039\/501100012544","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC 114-2320-B-039 -038 -MY3"],"award-info":[{"award-number":["NSTC 114-2320-B-039 -038 -MY3"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC 114-2320-B-039-073"],"award-info":[{"award-number":["NSTC 114-2320-B-039-073"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC 114-2320-B-039-005"],"award-info":[{"award-number":["NSTC 114-2320-B-039-005"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2027,3]]},"DOI":"10.1016\/j.biomaterials.2026.124638","type":"journal-article","created":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T06:39:17Z","timestamp":1789627157000},"page":"124638","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"PA","title":["Engineered \u03b19-nAChR-targeting antibodies attenuate nicotine-enhanced triple-negative breast cancer progression and exhibit favorable short-term tolerability in cynomolgus macaques"],"prefix":"10.1016","volume":"338","author":[{"given":"Chi-Hsin","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Yuan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuo-Hsiang","family":"Chuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-6311-7112","authenticated-orcid":false,"given":"Yu-Hsuan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-9922-331X","authenticated-orcid":false,"given":"Tzu-Chun","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4317-4740","authenticated-orcid":false,"given":"Mien-Chie","family":"Hung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu-Hai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shih-Hsin","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Yen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"You-Cheng","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Ching","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3649-6680","authenticated-orcid":false,"given":"Yuan-Soon","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.biomaterials.2026.124638_bib1","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s13058-017-0908-4","article-title":"Smoking and risk of breast cancer in the Generations Study cohort","volume":"19","author":"Jones","year":"2017","journal-title":"Breast Cancer Res."},{"issue":"12","key":"10.1016\/j.biomaterials.2026.124638_bib2","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1200\/JCO.2015.63.9328","article-title":"Cigarette smoking before and after breast cancer diagnosis: mortality from breast cancer and smoking-related diseases","volume":"34","author":"Passarelli","year":"2016","journal-title":"J. Clin. Oncol.official journal of the American Society of Clinical Oncology"},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124638_bib3","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.52371","article-title":"Association of cigarette smoking and alcohol consumption with subsequent mortality among Black breast cancer survivors in New Jersey","volume":"6","author":"Zeinomar","year":"2023","journal-title":"JAMA Netw. Open"},{"issue":"2","key":"10.1016\/j.biomaterials.2026.124638_bib4","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1093\/toxsci\/kfm060","article-title":"Nicotine promotes colon tumor growth and angiogenesis through beta-adrenergic activation","volume":"97","author":"Wong","year":"2007","journal-title":"Toxicol. Sci."},{"issue":"3","key":"10.1016\/j.biomaterials.2026.124638_bib5","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1093\/carcin\/bgp010","article-title":"Nicotine stimulates pancreatic cancer xenografts by systemic increase in stress neurotransmitters and suppression of the inhibitory neurotransmitter gamma-aminobutyric acid","volume":"30","author":"Al-Wadei","year":"2009","journal-title":"Carcinogenesis"},{"issue":"6","key":"10.1016\/j.biomaterials.2026.124638_bib6","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/nrc3725","article-title":"Connections of nicotine to cancer","volume":"14","author":"Grando","year":"2014","journal-title":"Nat. Rev. Cancer"},{"issue":"3","key":"10.1016\/j.biomaterials.2026.124638_bib7","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/nrc2590","article-title":"Is cancer triggered by altered signalling of nicotinic acetylcholine receptors?","volume":"9","author":"Schuller","year":"2009","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124638_bib8","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1158\/1541-7786.MCR-13-0541","article-title":"Nicotine-mediated cell proliferation and tumor progression in smoking-related cancers","volume":"12","author":"Schaal","year":"2014","journal-title":"Mol. Cancer Res. : MCR"},{"issue":"17","key":"10.1016\/j.biomaterials.2026.124638_bib9","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1093\/jnci\/djq300","article-title":"Overexpression and activation of the alpha9-nicotinic receptor during tumorigenesis in human breast epithelial cells","volume":"102","author":"Lee","year":"2010","journal-title":"J. Natl. Cancer Inst."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124638_bib10","doi-asserted-by":"crossref","first-page":"3131","DOI":"10.1038\/s41467-019-10920-8","article-title":"Membrane protein-regulated networks across human cancers","volume":"10","author":"Lin","year":"2019","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124638_bib11","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s10549-014-2912-z","article-title":"Nicotine promotes apoptosis resistance of breast cancer cells and enrichment of side population cells with cancer stem cell-like properties via a signaling cascade involving galectin-3, \u03b19 nicotinic acetylcholine receptor and STAT3","volume":"145","author":"Guha","year":"2014","journal-title":"Breast Cancer Res. Treat."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124638_bib12","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s12964-022-00934-z","article-title":"Alpha5 nicotinic acetylcholine receptor mediated immune escape of lung adenocarcinoma via STAT3\/Jab1-PD-L1 signalling","volume":"20","author":"Zhu","year":"2022","journal-title":"Cell Commun. Signal. : CCS"},{"issue":"9","key":"10.1016\/j.biomaterials.2026.124638_bib13","doi-asserted-by":"crossref","DOI":"10.3390\/jcm8091391","article-title":"Smoking as an independent risk factor for hepatocellular carcinoma due to the \u03b17-Nachr modulating the JAK2\/STAT3 signaling axis","volume":"8","author":"Li","year":"2019","journal-title":"J. Clin. Med."},{"issue":"4","key":"10.1016\/j.biomaterials.2026.124638_bib14","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1007\/s10456-024-09944-6","article-title":"The angiogenic role of the alpha 9-nicotinic acetylcholine receptor in triple-negative breast cancers","volume":"27","author":"Ochirbat","year":"2024","journal-title":"Angiogenesis"},{"issue":"2","key":"10.1016\/j.biomaterials.2026.124638_bib15","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/s41419-017-0224-z","article-title":"Nicotine associated breast cancer in smokers is mediated through high level of EZH2 expression which can be reversed by methyltransferase inhibitor DZNepA","volume":"9","author":"Kumari","year":"2018","journal-title":"Cell Death Dis."},{"issue":"4","key":"10.1016\/j.biomaterials.2026.124638_bib16","doi-asserted-by":"crossref","DOI":"10.3390\/md18040195","article-title":"\u03b1O-Conotoxin GeXIVA inhibits the growth of breast cancer cells via interaction with \u03b19 nicotine acetylcholine receptors","volume":"18","author":"Sun","year":"2020","journal-title":"Mar. Drugs"},{"issue":"12","key":"10.1016\/j.biomaterials.2026.124638_bib17","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11121991","article-title":"The alpha9 nicotinic acetylcholine receptor mediates nicotine-induced PD-L1 expression and regulates melanoma cell proliferation and migration","volume":"11","author":"Nguyen","year":"2019","journal-title":"Cancers (Basel)"},{"issue":"6","key":"10.1016\/j.biomaterials.2026.124638_bib18","doi-asserted-by":"crossref","DOI":"10.3390\/biom15060835","article-title":"alpha9 nicotinic acetylcholine receptor promotes tumor proliferation and suppresses ferroptosis in triple-negative breast cancer","volume":"15","author":"Feng","year":"2025","journal-title":"Biomolecules"},{"issue":"6","key":"10.1016\/j.biomaterials.2026.124638_bib19","doi-asserted-by":"crossref","DOI":"10.3390\/biom15060835","article-title":"\u03b19 nicotinic acetylcholine receptor promotes tumor proliferation and suppresses ferroptosis in triple-negative breast cancer","volume":"15","author":"Feng","year":"2025","journal-title":"Biomolecules"},{"key":"10.1016\/j.biomaterials.2026.124638_bib20","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/693424","article-title":"From smoking to cancers: novel targets to neuronal nicotinic acetylcholine receptors","volume":"2011","author":"Lee","year":"2011","journal-title":"Journal of oncology"},{"issue":"7","key":"10.1016\/j.biomaterials.2026.124638_bib21","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.bcp.2009.05.020","article-title":"Alpha9 nicotinic acetylcholine receptors and the treatment of pain","volume":"78","author":"McIntosh","year":"2009","journal-title":"Biochem. Pharmacol."},{"issue":"24","key":"10.1016\/j.biomaterials.2026.124638_bib22","doi-asserted-by":"crossref","first-page":"16204","DOI":"10.1021\/acs.jmedchem.2c00494","article-title":"Mechanism of action and structure-activity relationship of \u03b1-Conotoxin Mr1.1 at the Human \u03b19\u03b110 nicotinic acetylcholine receptor","volume":"65","author":"Liang","year":"2022","journal-title":"J. Med. Chem."},{"issue":"24","key":"10.1016\/j.biomaterials.2026.124638_bib23","doi-asserted-by":"crossref","DOI":"10.3390\/cells12242837","article-title":"Therapeutic monoclonal antibodies against cancer: present and future","volume":"12","author":"Delgado","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.biomaterials.2026.124638_bib24","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.crimmu.2021.03.002","article-title":"Hybridoma technology: is it still useful?","volume":"2","author":"Moraes","year":"2021","journal-title":"Curr Res Immunol"},{"issue":"4","key":"10.1016\/j.biomaterials.2026.124638_bib25","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1080\/19420862.2018.1445456","article-title":"When monoclonal antibodies are not monospecific: hybridomas frequently express additional functional variable regions","volume":"10","author":"Bradbury","year":"2018","journal-title":"mAbs"},{"issue":"6","key":"10.1016\/j.biomaterials.2026.124638_bib26","doi-asserted-by":"crossref","DOI":"10.3390\/toxins10060236","article-title":"Basics of antibody phage display technology","volume":"10","author":"Ledsgaard","year":"2018","journal-title":"Toxins"},{"issue":"2","key":"10.1016\/j.biomaterials.2026.124638_bib27","doi-asserted-by":"crossref","DOI":"10.3390\/v13020178","article-title":"Phage display technology as a powerful platform for antibody drug discovery","volume":"13","author":"Nagano","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.biomaterials.2026.124638_bib28","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.3389\/fimmu.2020.01986","article-title":"Phage display derived monoclonal antibodies: from bench to bedside","volume":"11","author":"Alfaleh","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biomaterials.2026.124638_bib29","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.3389\/fimmu.2017.01287","article-title":"Antibody or antibody fragments: implications for molecular imaging and targeted therapy of solid tumors","volume":"8","author":"Xenaki","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biomaterials.2026.124638_bib30","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.jconrel.2016.02.006","article-title":"Molecular engineering of high affinity single-chain antibody fragment for endothelial targeting of proteins and nanocarriers in rodents and humans","volume":"226","author":"Greineder","year":"2016","journal-title":"J. Contr. Release"},{"issue":"6","key":"10.1016\/j.biomaterials.2026.124638_bib31","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/S0896-6273(04)00115-1","article-title":"Nicotine and carbamylcholine binding to nicotinic acetylcholine receptors as studied in AChBP crystal structures","volume":"41","author":"Celie","year":"2004","journal-title":"Neuron"},{"issue":"11","key":"10.1016\/j.biomaterials.2026.124638_bib32","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1038\/nsmb.2900","article-title":"Crystal structures of free and antagonist-bound states of human alpha9 nicotinic receptor extracellular domain","volume":"21","author":"Zouridakis","year":"2014","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.biomaterials.2026.124638_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.ecoenv.2025.118071","article-title":"Mechanisms of reduced efficacy of HER2-targeted therapy in HER2-low breast cancer by long-term nicotine exposure in patient-derived xenograft mouse tumor models","volume":"294","author":"Lin","year":"2025","journal-title":"Ecotoxicol. Environ. Saf."},{"issue":"6","key":"10.1016\/j.biomaterials.2026.124638_bib34","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1021\/acs.chemrestox.5c00464","article-title":"The role of HGF\/c-Met\/PI3K\/AKT pathway regulated by \u03b17-nAChR\/\u03b22-AR in nicotine-promoted malignant progression of nonsmall cell lung cancer A549 cells","volume":"39","author":"Li","year":"2026","journal-title":"Chem. Res. Toxicol."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124638_bib35","doi-asserted-by":"crossref","DOI":"10.3390\/md18010061","article-title":"Differential expression of nicotine acetylcholine receptors associates with human breast cancer and mediates antitumor activity of \u03b1O-Conotoxin GeXIVA","volume":"18","author":"Sun","year":"2020","journal-title":"Mar. Drugs"},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124638_bib36","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1039\/D1BM01218E","article-title":"A novel anti-tumor\/anti-tumor-associated fibroblast\/anti-mPEG tri-specific antibody to maximize the efficacy of mPEGylated nanomedicines against fibroblast-rich solid tumor","volume":"10","author":"Chen","year":"2021","journal-title":"Biomater. Sci."},{"issue":"37","key":"10.1016\/j.biomaterials.2026.124638_bib37","doi-asserted-by":"crossref","first-page":"9930","DOI":"10.1016\/j.biomaterials.2014.08.032","article-title":"One-step mixing with humanized anti-mPEG bispecific antibody enhances tumor accumulation and therapeutic efficacy of mPEGylated nanoparticles","volume":"35","author":"Kao","year":"2014","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124638_bib38","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s40364-024-00715-5","article-title":"Histamine N-methyltransferase (HNMT) as a potential auxiliary biomarker for predicting adaptability to anti-HER2 drug treatment in breast cancer patients","volume":"13","author":"Cheng","year":"2025","journal-title":"Biomark. Res."},{"issue":"22","key":"10.1016\/j.biomaterials.2026.124638_bib39","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1093\/hmg\/ddae132","article-title":"Investigation of the \u03b19-nicotinic receptor single nucleotide polymorphisms induced oncogenic properties and molecular mechanisms in breast cancer","volume":"33","author":"Liao","year":"2024","journal-title":"Hum. Mol. Genet."},{"issue":"15","key":"10.1016\/j.biomaterials.2026.124638_bib40","doi-asserted-by":"crossref","first-page":"3799","DOI":"10.1111\/j.1742-4658.2007.05935.x","article-title":"Muscle and neuronal nicotinic acetylcholine receptors. Structure, function and pathogenicity","volume":"274","author":"Kalamida","year":"2007","journal-title":"FEBS J."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124638_bib41","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1093\/aje\/kwm045","article-title":"Smoking cigarettes before first childbirth and risk of breast cancer","volume":"166","author":"Ha","year":"2007","journal-title":"Am. J. Epidemiol."},{"issue":"2","key":"10.1016\/j.biomaterials.2026.124638_bib42","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1001\/archinternmed.2010.503","article-title":"Cigarette smoking and the incidence of breast cancer","volume":"171","author":"Xue","year":"2011","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.biomaterials.2026.124638_bib43","doi-asserted-by":"crossref","first-page":"336","DOI":"10.3389\/fncel.2017.00336","article-title":"Nicotinic acetylcholine receptor subtype Alpha-9 mediates triple-negative breast cancers based on a spontaneous pulmonary metastasis mouse model","volume":"11","author":"Huang","year":"2017","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.biomaterials.2026.124638_bib44","article-title":"alpha9-Containing nicotinic receptors in cancer","volume":"15","author":"Pucci","year":"2021","journal-title":"Front. Cell. Neurosci."},{"issue":"6","key":"10.1016\/j.biomaterials.2026.124638_bib45","doi-asserted-by":"crossref","DOI":"10.3390\/md22060252","article-title":"\u03b1O-Conotoxin GeXIVA[1,2] suppresses in vivo tumor growth of triple-negative breast cancer by inhibiting AKT-mTOR, STAT3 and NF-\u03baB signaling mediated proliferation and inducing apoptosis","volume":"22","author":"Guo","year":"2024","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.biomaterials.2026.124638_bib46","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.omtn.2023.07.013","article-title":"Tumor targeting and therapeutic assessments of RNA nanoparticles carrying \u03b19-nAChR aptamer and anti-miR-21 in triple-negative breast cancers, molecular therapy","volume":"33","author":"Liao","year":"2023","journal-title":"Nucleic acids"},{"issue":"4","key":"10.1016\/j.biomaterials.2026.124638_bib47","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1158\/1535-7163.MCT-14-0924","article-title":"Nonclinical safety evaluation of VX15\/2503, a humanized IgG4 Anti-SEMA4D antibody","volume":"14","author":"Leonard","year":"2015","journal-title":"Mol. Cancer Therapeut."},{"issue":"6","key":"10.1016\/j.biomaterials.2026.124638_bib48","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1158\/1535-7163.MCT-19-0774","article-title":"Biophysical and immunological characterization and in vivo pharmacokinetics and toxicology in Nonhuman Primates of the Anti-PD-1 antibody pembrolizumab","volume":"19","author":"Hutchins","year":"2020","journal-title":"Mol. Cancer Therapeut."},{"issue":"11","key":"10.1016\/j.biomaterials.2026.124638_bib49","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1007\/s00262-025-04142-9","article-title":"Nonclinical safety evaluation and pharmacokinetics of Ab612, a novel anti-L1CAM (CD171) therapeutic antibody candidate against solid cancer","volume":"74","author":"Kim","year":"2025","journal-title":"Cancer Immunol. Immunother. : CII"},{"issue":"2","key":"10.1016\/j.biomaterials.2026.124638_bib50","doi-asserted-by":"crossref","first-page":"52","DOI":"10.37796\/2211-8039.1708","article-title":"Unveiling immune-related gene signatures in triple negative breast cancer through integrated transcriptomic analysis","volume":"16","author":"Paranthaman","year":"2026","journal-title":"Biomedicine"},{"issue":"6","key":"10.1016\/j.biomaterials.2026.124638_bib51","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s40291-024-00734-w","article-title":"Clinical progresses and challenges of bispecific antibodies for the treatment of solid tumors","volume":"28","author":"Gu","year":"2024","journal-title":"Mol. Diagn. Ther."},{"issue":"9","key":"10.1016\/j.biomaterials.2026.124638_bib52","doi-asserted-by":"crossref","first-page":"3583","DOI":"10.1016\/j.apsb.2023.05.023","article-title":"Bispecific antibodies in cancer therapy: target selection and regulatory requirements","volume":"13","author":"Sun","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124638_bib53","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/s12943-025-02390-y","article-title":"Bispecific antibodies: unleashing a new era in oncology treatment","volume":"24","author":"Shui","year":"2025","journal-title":"Mol. Cancer"},{"issue":"8","key":"10.1016\/j.biomaterials.2026.124638_bib54","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.trecan.2024.06.001","article-title":"Current landscape of CD3 bispecific antibodies in hematologic malignancies","volume":"10","author":"Kassner","year":"2024","journal-title":"Trends Cancer"},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124638_bib55","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1038\/s41467-023-37029-3","article-title":"An anti-HER2 biparatopic antibody that induces unique HER2 clustering and complement-dependent cytotoxicity","volume":"14","author":"Weisser","year":"2023","journal-title":"Nat. Commun."},{"issue":"9","key":"10.1016\/j.biomaterials.2026.124638_bib56","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1080\/14712598.2025.2556903","article-title":"An evaluation of zanidatamab, a novel, anti-HER2 biparatopic antibody, for the treatment of biliary tract cancer","volume":"25","author":"Yoon","year":"2025","journal-title":"Expert Opin. Biol. Ther."},{"key":"10.1016\/j.biomaterials.2026.124638_bib57","series-title":"Phage Display: a Laboratory Manual","author":"Barbas","year":"2001"},{"issue":"2","key":"10.1016\/j.biomaterials.2026.124638_bib58","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1556\/EuJMI.4.2014.2.1","article-title":"Production of recombinant antibodies using bacteriophages","volume":"4","author":"Shukra","year":"2014","journal-title":"Eur. J. Microbiol. Immunol."},{"key":"10.1016\/j.biomaterials.2026.124638_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.ecoenv.2025.119303","article-title":"Inotilone suppresses fibronectin 1 expression and inhibits the growth of triple-negative breast cancer xenografts under prolonged nicotine exposure","volume":"306","author":"Lin","year":"2025","journal-title":"Ecotoxicol. Environ. Saf."},{"issue":"6","key":"10.1016\/j.biomaterials.2026.124638_bib60","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1097\/SLA.0b013e3181a6ce7e","article-title":"Tobacco-specific carcinogen enhances colon cancer cell migration through alpha7-nicotinic acetylcholine receptor","volume":"249","author":"Wei","year":"2009","journal-title":"Ann. Surg."},{"issue":"Suppl 3","key":"10.1016\/j.biomaterials.2026.124638_bib61","doi-asserted-by":"crossref","first-page":"S580","DOI":"10.1245\/s10434-011-2064-x","article-title":"NNK enhances cell migration through \u03b17-nicotinic acetylcholine receptor accompanied by increased of fibronectin expression in gastric cancer","volume":"19","author":"Wang","year":"2012","journal-title":"Ann. Surg Oncol."}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961226006629?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961226006629?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T01:41:23Z","timestamp":1793324483000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961226006629"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,3]]},"references-count":61,"alternative-id":["S0142961226006629"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2026.124638","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2027,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Engineered \u03b19-nAChR-targeting antibodies attenuate nicotine-enhanced triple-negative breast cancer progression and exhibit favorable short-term tolerability in cynomolgus macaques","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2026.124638","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"124638"}}